Local in vivo administration of a decoy oligonucleotide targeting NF-κB induces apoptosis of osteoclasts after application of orthodontic forces to rat teeth

International Journal of Molecular Medicine

Volumn 18, Issue 5, 2006, Pages 807-811

  Penolazzi, Letizia ^a   Magri, Eros ^a   Lambertini, Elisabetta ^a   Calò, Girolamo ^a   Cozzani, Mauro ^a   Siciliani, Giuseppe ^a   Piva, Roberta ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Nuclear factor B; Orthodontic tooth movement; Osteoclasts; Transcription factor decoy

Indexed keywords

DNA; NF KAPPAB DECOY; NF-KAPPAB DECOY; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL; APOPTOSIS; ARTICLE; CYTOLOGY; DRUG EFFECT; MALE; MECHANICAL STRESS; NICK END LABELING; OSTEOCLAST; RAT; TOOTH; WISTAR RAT;

ANIMALS; APOPTOSIS; DNA; IN SITU NICK-END LABELING; MALE; OLIGODEOXYRIBONUCLEOTIDES; OSTEOCLASTS; RATS; RATS, WISTAR; STRESS, MECHANICAL; TOOTH;

EID: 34447638156     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.5.807     Document Type: Article

References (24)

1. Dzau VJ: Transcriptional factor decoy. Circ Res 90: 1234-1236, 2002.
2. Mann MJ and Dzau VJ: Therapeutic application of transcriptional factor decoy oligonucleotides. J Clin Invest 106: 1071-1075, 2000.
3. Penolazzi L, Borgatti M, Lambertini E, Mischiati C, Finotti A, Romanelli A, Saviano M, Pedone C, Piva R and Gambari R: Peptide nucleic acid-DNA decoy chimeras targeting NF-κB transcription factors: Induction of apoptosis in human primary osteoclasts. Int J Mol Med 14: 145-152, 2004.
4. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J and Ogihara T: In vivo transfection of cis element 'decoy' against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 3: 894-899, 1997.
5. Tomita T, Takano H, Tomita N, Morishita R, Kaneko M, Shi K, Takahi K, Nakase T, Kaneda Y, Yoshikawa H and Ochi T: Transcription factor decoy for NF-κB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rheumatology 39: 749-757, 2000.
6. Karin M and Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002.
7. Yamamoto Y and Gaynor RB: Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 1: 287-296, 2001.
8. Yang X and Karsenty G: Transcription factors in bone: developmental and pathological aspects. Trends Mol Med 8: 340-345, 2002.
9. Chaisson ML, Branstetter DG, Derry JM, Armstrong AP, Tometsko ME, Takeda K, Akira S and Dougall WC: Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha. J Biol Chem 279: 54841-54848, 2004.
10. Roodman GD: Advances in bone biology: the osteoclasts. Endocr Rev 17: 308-332, 1996.
11. Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature 423: 337-342, 2003.
12. Blair HC, Robinson LJ and Zaidi M: Osteoclast signaling pathways. Biochem Biophys Res Commun 328: 728-738, 2005.
13. Kaplan FS, Horowitz SM and Quinn PD: Dental complications of Paget's disease: the need for hard facts about hard tissues. Calcif Tissue Int 53: 223-234, 1993.
14. Laurin N, Brown JP, Morissette J and Raymond V: Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70: 1582-1588, 2002.
15. Boyce BF, Yamashita T, Yao Z, Zhang Q, Li F and Xing L: Roles for NF-kappaB and c-Fos in osteoclasts. J Bone Miner Metab 23: 11-15, 2005.
16. Helfrich MH: Osteoclast diseases and dental abnormalities. Arch Oral Biol 50: 115-122, 2005.
17. Wang LC, Takahashi I, Sasano Y, Sugawara J and Mitani H: Osteoclastogenic activity during mandibular distraction osteogenesis. J Dent Res 84: 1010-1015, 2005.
18. Low E, Zoellner H, Kharbanda OP and Darendeliler MA: Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa beta ligand (RANKL) during root resorption induced by the application of heavy orthodontic forces on rat molars. Am J Orthod Dentofacial Orthop 128: 497-503, 2005.
19. Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, Giovannini I, Naccari R, Siciliani G and Gambari R: Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol 66: 1189-1198, 2003.
20. King GJ, Keeling SD and Wronski TJ: Histomorphometric study of alveolar bone turnover in orthodontic tooth movement. Bone 12: 401-409, 1991.
21. Wu X, McKenna MA, Feng X, Nagy TR and McDonald JM: Osteoclast apoptosis: The role of Fas in vivo and in vitro. Endocrinology 144: 5545-5555, 2003.
22. Xing L and Boyce BF: Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem Biophys Res Commun 328: 709-720, 2005.
23. Piva R and Gambari R: Induction of apoptosis of human osteoclasts by the transcription factor decoy approach: relevance for the treatment of rheumatoid arthritis. Minerva Biotecnologica 16: 135-143, 2004.
24. Gambari R: New trends for the development of novel decoy molecules against nuclear factor kappa-B (NF-κB) transcription factor. Minerva Biotecnologica 16: 145-149, 2004.